Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
An interview with Franco Negron
In this interview, we spoke with Franco Negron, CEO of Simtra, about how the company is advancing its position as a premier CDMO for sterile injectables while preparing for the next wave of complex biologics. read more
Safely Scaling Highly Potent API manufacturing
Ever more drug developers are searching for CDMOs with contamination-limiting capabilities. But how can they know which have these high-potency credentials? read more
An Interview With Franco Negron
Simtra’s capability to support high-volume injectables and lower-volume modalities provides balanced expertise across the sterile injectables landscape. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Cambrex High Point Clears FDA, PMDA and TGA Pre-Approval Inspections
Tuesday, August 25, 2026
Cambrex has completed pre-approval inspections by the U.S. FDA, Japan’s Pharmaceuticals and Medical Devices Agency and Australia’s Therapeutic Goods ... read more
Halo Pharma Nears Launch of $45M Sterile Injectable Line
Tuesday, August 25, 2026
Halo Pharma is in the final operational stages of activating a new sterile injectable manufacturing line at its Whippany, New Jersey, facility, ... read more
Hovione Completes €40M Loures Tablet Manufacturing Expansion
Tuesday, August 25, 2026
Hovione has completed a more than €40 million expansion of its tablet development and manufacturing center in Loures, Portugal, adding commercial-... read more
Chai Discovery, Bristol Myers Squibb Partner on AI Antibody Discovery
Tuesday, August 25, 2026
Chai Discovery has entered a collaboration with Bristol Myers Squibb to support the discovery of therapeutic antibody candidates using artificial ... read more
VectorBuilder, Lir Partner to Engineer More Manufacturable AAV Capsids
Thursday, August 20, 2026
VectorBuilder and Lir Therapeutics have formed a strategic collaboration to develop adeno-associated virus capsids designed to combine biological ... read more